FDA.reportPublic FDA data

crisaborole 2 % Topical Ointment

RxCUI
1865957
RxNorm name
crisaborole 2 % Topical Ointment
Display name
crisaborole 2 % Topical Ointment
Full name
crisaborole 2 % Topical Ointment
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:00

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EucrisaCRISABOROLEPfizer Laboratories Div Pfizer Inc609b77de-1ca3-4783-b8f5-01a9c0f1d77d2025-09-23Warnings, Adverse reactionsExact identifier
rxcui: 1865957

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
609b77de-1ca3-4783-b8f5-01a9c0f1d77dcrisaborole 2 % Topical Ointment [PSN] · crisaborole 0.02 MG/MG Topical Ointment [SCD] · crisaborole 2 % Topical Ointment [SY]313These highlights do not include all the information needed to use EUCRISA safely and effectively. See full prescribing information for EUCRISA. EUCRISA ® (crisaborole) ointment, for topical use Initial U.S. Approval: 201620250923